Clinical Trials · NCT07317115
Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- GT Metabolic Solutions, Inc.
- Enrollment
- 20
- Start date
- Mar 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Functional improvement of T2D: HbA1c